These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4562436)

  • 41. [Indications for bone marrow and peripheral stem cell transplantation in malignant hematological diseases].
    Gratwohl A
    Ther Umsch; 1996 Feb; 53(2):152-7. PubMed ID: 8629266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibody formation in a cell culture in vivo].
    Man'ko VM
    Usp Sovrem Biol; 1967; 63(1):110-34. PubMed ID: 4898892
    [No Abstract]   [Full Text] [Related]  

  • 44. [Animal models for intractable hematologic disorders].
    Ikehara S
    Rinsho Ketsueki; 1994 May; 35(5):446-53. PubMed ID: 8028191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
    Elfenbein GJ
    Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
    Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
    J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ability of normal bone marrow to restore second-set immunity.
    Kongshavn PA; Lapp WS; Hinchey EJ
    Transplant Proc; 1971 Mar; 3(1):437-9. PubMed ID: 4937913
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
    Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3530. PubMed ID: 8540085
    [No Abstract]   [Full Text] [Related]  

  • 50. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New possibilities of donor selection for bone marrow and organ transplantation by HLA typing and genomic DNA].
    Lattermann A; Schoppet M; Mueller-Eckhardt G
    Beitr Infusionsther Transfusionsmed; 1994; 32():256-60. PubMed ID: 9480102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow transplantation in children. Nursing management of late effects.
    van der Wal R; Nims J; Davies B
    Cancer Nurs; 1988 Jun; 11(3):132-43. PubMed ID: 3042124
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of the nurse in the bone marrow unit.
    O'Leary S
    World Ir Nurs; 1985; 4(3):5-6. PubMed ID: 3895757
    [No Abstract]   [Full Text] [Related]  

  • 54. [ON THE USE OF CADAVERIC BONE MARROW FOR THERAPEUTIC PURPOSES].
    KURDYBAILO FV; ELESHIN IuN
    Probl Gematol Pereliv Krovi; 1965 Feb; 10():51. PubMed ID: 14262931
    [No Abstract]   [Full Text] [Related]  

  • 55. Blood and marrow transplant: it's not just for cancer.
    Eisenberg S
    ONS Connect; 2012 Nov; 27(11):22. PubMed ID: 23316526
    [No Abstract]   [Full Text] [Related]  

  • 56. Stressors and responses during bone marrow transplantation.
    Popkin MK; Moldow CF
    Arch Intern Med; 1977 Jun; 137(6):725. PubMed ID: 326211
    [No Abstract]   [Full Text] [Related]  

  • 57. Bone marrow transfusion in blood diseases. (Observations in 9 cases).
    NICOLAU CT; APATEANU V; NICOARA S; GRIGORIU G
    Rum Med Rev; 1961; 5():33-5. PubMed ID: 14479518
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone marrow transplantation for the treatment of hematologic diseases: status in 1994.
    Beatty PG
    Exp Hematol; 1995 Mar; 23(3):277-88. PubMed ID: 7875245
    [No Abstract]   [Full Text] [Related]  

  • 59. [Molecular biology and clinical study of hematologic diseases].
    Saito H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1371-9. PubMed ID: 8537737
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hematology in 1978].
    Varet B
    Rev Prat; 1978 Jun; 28(35):2689-709. PubMed ID: 353963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.